正海生物: 董事会决议公告

Group 1 - The board of directors of Yantai Zhenghai Biological Technology Co., Ltd. held its eighth meeting of the fourth session on August 4, 2025, via telecommunication, with all 8 directors present [1] - The meeting approved the company's 2025 semi-annual report and its summary, confirming that the preparation process complies with relevant laws and regulations, and accurately reflects the company's actual situation [2][3] Group 2 - The board unanimously agreed to amend the company's articles of association and related rules, and to change the business scope, with details to be disclosed on the designated information disclosure website [3][5] - The board accepted the resignation of non-independent director Ni Ting and nominated Xu Yueli as a candidate for the non-independent director position [3][4] Group 3 - The board decided to dissolve the Strategic and Investment Committee, transferring its responsibilities to the board itself to enhance decision-making efficiency for major investments and financing [4] - The board approved several governance documents, including the establishment of a "Management System for Departing Directors and Senior Management" and modifications to various existing governance rules, all receiving unanimous support [5][6][7][8][9] Group 4 - The company plans to hold its first extraordinary shareholders' meeting of 2025 on August 27, 2025, to review the proposals discussed in the board meeting [9]